Corindus Vascular Robotics to Report First Quarter 2017 Financial Results on May 9, 2017

Business Wire 21-Apr-2017 4:30 PM

WALTHAM, Mass.--(BUSINESS WIRE)-- Corindus Vascular Robotics, Inc. (NYSE MKT: CVRS), a leading developer of precision vascular robotics, announced today that it will release financial and business results for the first quarter of 2017 after the close of trading on Tuesday, May 9, 2017. The Companys management team will host a corresponding conference call beginning at 4:30 p.m. ET to discuss the financial results and recent business developments.

Investors interested in listening to the conference call may do so by dialing (877) 201-0168 for domestic callers or (647) 788-4901 for international callers (Conference ID: 5584634), or from the webcast on the Investor Relations section of the Companys website at: Following the call, an audio replay will be available on the Investor Relations section of the Companys website.

About Corindus Vascular Robotics, Inc.

Corindus Vascular Robotics, Inc. is a global technology leader in robotic-assisted vascular interventions. The company's CorPath System is the first FDA-cleared medical device to bring robotic precision to percutaneous coronary interventions. During the procedure, the interventional cardiologist sits at a radiation-shielded workstation to advance guide catheters, stents, and guidewires with millimeter-by-millimeter precision. The workstation allows the physician greater control and the freedom from wearing heavy lead protective equipment that causes musculoskeletal injuries. With the CorPath System, Corindus Vascular Robotics brings robotic precision to interventional procedures to help optimize clinical outcomes and minimize the costs associated with complications of improper stent placement during manual procedures. Corindus stands behind its product with its unique $1,000 hospital credit "One Stent Program." For additional information, visit, and follow @CorindusInc.

Image for Press Release 424111

View source version on

Corindus Vascular Robotics, Inc. Kate Stanton, 508-653-3335 Ext. 200Kate.stanton@corindus.comorLynn Pieper Lewis,

Source: Corindus Vascular Robotics, Inc.

Wait, Before You Leave...

Receive Anticipated Price Moves into Earnings

Enter your email address below to receive FREE daily information about expected earnings moves and upcoming earnings.
Market Chameleon